Progyny, Inc. (PGNY) Stock Overview
Explore Progyny, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Progyny, Inc. (PGNY)
Key Financials
Key Financials
Market Cap
2.7B
P/E Ratio
31.62
EPS (TTM)
$0.97
ROE
0.20%
PGNY Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Progyny, Inc. (NASDAQ: PGNY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Progyny, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PGNY on the NASDAQ shows an RSI of 81.51, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $24.69 for the NASDAQ listing.
Key metrics behind Progyny, Inc.'s NASDAQ-traded stock include a P/E ratio of 31.62 and a market capitalization of 2.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PGNY on the NASDAQ.